Common variants in breast cancer risk loci predispose to distinct tumor subtypes

Author:

Ahearn Thomas U.ORCID,Zhang Haoyu,Michailidou Kyriaki,Milne Roger L.,Bolla Manjeet K.,Dennis Joe,Dunning Alison M.,Lush Michael,Wang Qin,Andrulis Irene L.,Anton-Culver Hoda,Arndt Volker,Aronson Kristan J.,Auer Paul L.,Augustinsson Annelie,Baten Adinda,Becher Heiko,Behrens Sabine,Benitez Javier,Bermisheva Marina,Blomqvist Carl,Bojesen Stig E.,Bonanni Bernardo,Børresen-Dale Anne-Lise,Brauch Hiltrud,Brenner Hermann,Brooks-Wilson Angela,Brüning Thomas,Burwinkel Barbara,Buys Saundra S.,Canzian Federico,Castelao Jose E.,Chang-Claude Jenny,Chanock Stephen J.,Chenevix-Trench Georgia,Clarke Christine L.,Sahlberg Kristine K.,Ottestad Lars,Kåresen Rolf,Schlichting Ellen,Holmen Marit Muri,Sauer Toril,Haakensen Vilde,Engebråten Olav,Naume Bjørn,Fosså Alexander,Kiserud Cecile E.,Reinertsen Kristin V.,Helland Åslaug,Riis Margit,Geisler Jürgen,Collée J. Margriet,Cox Angela,Cross Simon S.,Czene Kamila,Daly Mary B.,Devilee Peter,Dörk Thilo,Dwek Miriam,Eccles Diana M.,Evans D. Gareth,Fasching Peter A.,Figueroa Jonine,Floris Giuseppe,Gago-Dominguez Manuela,Gapstur Susan M.,García-Sáenz José A.,Gaudet Mia M.,Giles Graham G.,Goldberg Mark S.,González-Neira Anna,Alnæs Grethe I. Grenaker,Grip Mervi,Guénel Pascal,Haiman Christopher A.,Hall Per,Hamann Ute,Harkness Elaine F.,Heemskerk-Gerritsen Bernadette A. M.,Holleczek Bernd,Hollestelle Antoinette,Hooning Maartje J.,Hoover Robert N.,Hopper John L.,Howell Anthony,Clarke Christine,Balleine Rosemary,Baxter Robert,Braye Stephen,Carpenter Jane,Dahlstrom Jane,Forbes John,Lee CSoon,Marsh Deborah,Morey Adrienne,Pathmanathan Nirmala,Scott Rodney,Simpson Peter,Spigelman Allan,Wilcken Nicholas,Yip Desmond,Zeps Nikolajs,Fox Stephen,Campbell Ian,Bowtell David,Chenevix-Trench Georgia,Spurdle Amanda,Webb Penny,de Fazio Anna,Tassell Margaret,Kirk Judy,Lindeman Geoff,Price Melanie,Southey Melissa,Milne Roger,Deb Sid,Jakimovska Milena,Jakubowska Anna,John Esther M.,Jones Michael E.,Jung Audrey,Kaaks Rudolf,Kauppila Saila,Keeman Renske,Khusnutdinova Elza,Kitahara Cari M.,Ko Yon-Dschun,Koutros Stella,Kristensen Vessela N.,Krüger Ute,Kubelka-Sabit Katerina,Kurian Allison W.,Kyriacou Kyriacos,Lambrechts Diether,Lee Derrick G.,Lindblom Annika,Linet Martha,Lissowska Jolanta,Llaneza Ana,Lo Wing-Yee,MacInnis Robert J.,Mannermaa Arto,Manoochehri Mehdi,Margolin Sara,Martinez Maria Elena,McLean Catriona,Meindl Alfons,Menon Usha,Nevanlinna Heli,Newman William G.,Nodora Jesse,Offit Kenneth,Olsson Håkan,Orr Nick,Park-Simon Tjoung-Won,Patel Alpa V.,Peto Julian,Pita Guillermo,Plaseska-Karanfilska Dijana,Prentice Ross,Punie Kevin,Pylkäs Katri,Radice Paolo,Rennert Gad,Romero Atocha,Rüdiger Thomas,Saloustros Emmanouil,Sampson Sarah,Sandler Dale P.,Sawyer Elinor J.,Schmutzler Rita K.,Schoemaker Minouk J.,Schöttker Ben,Sherman Mark E.,Shu Xiao-Ou,Smichkoska Snezhana,Southey Melissa C.,Spinelli John J.,Swerdlow Anthony J.,Tamimi Rulla M.,Tapper William J.,Taylor Jack A.,Teras Lauren R.,Terry Mary Beth,Torres Diana,Troester Melissa A.,Vachon Celine M.,van Deurzen Carolien H. M.,van Veen Elke M.,Wagner Philippe,Weinberg Clarice R.,Wendt Camilla,Wesseling Jelle,Winqvist Robert,Wolk Alicja,Yang Xiaohong R.,Zheng Wei,Couch Fergus J.,Simard Jacques,Kraft Peter,Easton Douglas F.,Pharoah Paul D. P.,Schmidt Marjanka K.,García-Closas Montserrat,Chatterjee Nilanjan, , ,

Abstract

Abstract Background Genome-wide association studies (GWAS) have identified multiple common breast cancer susceptibility variants. Many of these variants have differential associations by estrogen receptor (ER) status, but how these variants relate with other tumor features and intrinsic molecular subtypes is unclear. Methods Among 106,571 invasive breast cancer cases and 95,762 controls of European ancestry with data on 173 breast cancer variants identified in previous GWAS, we used novel two-stage polytomous logistic regression models to evaluate variants in relation to multiple tumor features (ER, progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) and grade) adjusting for each other, and to intrinsic-like subtypes. Results Eighty-five of 173 variants were associated with at least one tumor feature (false discovery rate < 5%), most commonly ER and grade, followed by PR and HER2. Models for intrinsic-like subtypes found nearly all of these variants (83 of 85) associated at p < 0.05 with risk for at least one luminal-like subtype, and approximately half (41 of 85) of the variants were associated with risk of at least one non-luminal subtype, including 32 variants associated with triple-negative (TN) disease. Ten variants were associated with risk of all subtypes in different magnitude. Five variants were associated with risk of luminal A-like and TN subtypes in opposite directions. Conclusion This report demonstrates a high level of complexity in the etiology heterogeneity of breast cancer susceptibility variants and can inform investigations of subtype-specific risk prediction.

Funder

Genome Canada and the Canadian Institutes of Health Research

Génome Québec

Foundation for the National Institutes of Health

Center for Inherited Disease Research

Cancer Research UK

Odense University Hospital Research Foundation

National R&D Program for Cancer Control–Ministry of Health and Welfare

Italian Association for Cancer Research

Carol M. Baldwin Breast Cancer Research Fund

National Health and Medical Research Council

Deutsche Kinderkrebsstiftung

European Union

National Institutes of Health

National Cancer Institute

Canadian Institutes of Health Research

Susan G. Komen for the Cure, Komen Wyoming Affiliate

Ovarian Cancer Research Fund

National Human Genome Research Institute

Publisher

Springer Science and Business Media LLC

Reference48 articles.

1. Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70.

2. Curigliano G, Burstein HJ, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ et al: De-escalating and escalating treatments for early-stage breast cancer: the St Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017. Ann Oncol 2017, 28(8):1700–1712.

3. Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thurlimann B, Senn HJ. Panel m: personalizing the treatment of women with early breast cancer: highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2013. Ann Oncol. 2013;24(9):2206–23.

4. Barnard ME, Boeke CE, Tamimi RM. Established breast cancer risk factors and risk of intrinsic tumor subtypes. Biochim Biophys Acta. 2015;1856(1):73–85.

5. Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst. 2011;103(3):250–63.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3